# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014410
Filing Date
2023-08-10
Accepted
2023-08-10 08:01:45
Documents
52
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ewtx-20230630x10q.htm iXBRL | 10-Q | 1893645
2 | EX-31.1 | ewtx-20230630xex31d1.htm | EX-31.1 | 19403
3 | EX-31.2 | ewtx-20230630xex31d2.htm | EX-31.2 | 19216
4 | EX-32.2 | ewtx-20230630xex32d2.htm | EX-32.2 | 7610
5 | EX-32.1 | ewtx-20230630xex32d1.htm | EX-32.1 | 7533
| Complete submission text file | 0001558370-23-014410.txt |  | 5892275

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | ewtx-20230630.xsd | EX-101.SCH | 31590
7 | EX-101.CAL | ewtx-20230630_cal.xml | EX-101.CAL | 36236
8 | EX-101.DEF | ewtx-20230630_def.xml | EX-101.DEF | 122877
9 | EX-101.LAB | ewtx-20230630_lab.xml | EX-101.LAB | 324150
10 | EX-101.PRE | ewtx-20230630_pre.xml | EX-101.PRE | 228302
46 | EXTRACTED XBRL INSTANCE DOCUMENT | ewtx-20230630x10q_htm.xml | XML | 880492

Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40236 | Film No.: 231157250
SIC: 2834 Pharmaceutical Preparations